The systematic review of compoud Danshen dripping pills in treatment of coronary heart diseaseZHANG Jian, ZHANG Min-zhou, WANG Lei465-468,524
The international technical requirements on the preclinical toxicity studies and the inspirations to the R&D of new drugs in ChinaLaura Luo, Michael Shao, Lina Svedlund469-472
A specific drug to treat PKU:sapropterin dihydrochlorideWU Ye-hong, LIU Hai-jing, WANG Yu-hong478-479
Ecologically legal environment of independent technical innovation in the industry of traditional Chinese medicineZHOU Fang480-485
Establishment of the systems for the Chinese herbal medicine by setting protective geographical indicationsDONG Zuo-jun, HUANG Wen-long486-488,506
General consideration for nonclinical safety evaluation of new anticancer drugsWANG Hai-xue, WANG Qing-li, PENG Jian, LIAO Ming-yang489-491,544
Progress in clinical applications of selective COX-2 inhibitors——interpreting an American College of Rheumatology white paperZHU Jian, HUANG Feng497-501,552
Progress in research of multi-targeted inhibitors of receptor tyrosine kinaseTANG Hai-tao, CHEN Guo-guang, FANG Zheng, WANG Wei, WEI Ping502-506